OQL-051

N/A

Report date: 2023/06/07 14:36:08
NME

Base Information

Drug NameOQL-051
Drug Alias NameOQL-051
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors
TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 6
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOnquality Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesOnquality Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsDiarrhea
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A